Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60

Virology

Volumn 306, Issue 1, 2003, Pages 18-24

  Jin, Hong ^a   Lu, Bin ^a   Zhou, Helen ^a   Ma, Chienhui ^a   Zhao, Jackie ^a   Yang, Chin Fen ^a   Kemble, George ^a   Greenberg, Harry ^a  

^a MEDIMMUNE   (United States)

Author keywords

FluMist vaccine; Influenza A virus; Temperature sensitivity

Indexed keywords

AMINO ACID; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN COS7; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC STABILITY; INFLUENZA VIRUS A; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TEMPERATURE SENSITIVE MUTANT; VIRUS CHARACTERIZATION; VIRUS CULTURE; VIRUS GENE; VIRUS RECOMBINANT; VIRUS STRAIN;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0037293142     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00035-1     Document Type: Article

References (20)

1. Barnett E.D. Influenza immunization for children. N. Engl. J. Med. 338:1998;1459-1461.
2. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., Bernstein D.I., Hayden F.G., Kotloff K., Zangwill K., Iacuzio D., Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1998;1405-1412.
3. Boyce T.G., Hsu H.H., Sannella E.C., Coleman-Dockery S.D., Baylis E., Zhu Y., Barchfeld G., DiFrancesco A., Paranandi M., Culley B., Neuzil K.M., Wright P.F. Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine. 19:2000;217-226.
4. Cattaneo R. Biased (A → I) hypermutation of animal RNA virus genomes. Curr. Opin. Genet. Dev. 4:1994;895-900.
5. Edwards K.M., Dupont W.D., Westrich M.K., Plummer W.D. Jr., Palmer P.S., Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 169:1994;68-76.
6. Herlocher M.L., Clavo A.C., Maassab H.F. Sequence comparisons of A/AA/6/60 influenza viruses mutations which may contribute to attenuation. Virus Res. 42:1996;11-25.
7. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA. 97:2000;6108-6113.
8. Klimov A.I., Cox N.J., Yotov W.V., Rocha E., Alexandrova G.I., Kendal A.P. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology. 186:1992;795-797.
9. Maassab H.F. Adaptation and growth characteristics of influenza virus at 25 degrees C. Nature. 213:1967;612-614.
10. Maassab H.F., Kendal A.P., Abrams G.D., Monto A.S. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J. Infect. Dis. 146:1982;780-790.
11. Murphy B.R., Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol. 15:2002;295-323.
12. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., Glezen W.P., Wittes J. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults a randomized controlled trial. JAMA. 282:1999;137-144.
13. Parkin N.T., Chiu P., Coelingh K.L. Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis. Virus Res. 46:1996;31-44.
14. Richman D.D., Murphy B.R. The association of the temperature-sensitive phenotype with viral attenuation in animals and humans implications for the development and use of live virus vaccines. Rev. Infect. Dis. 1:1979;413-433.
15. Scholtissek C., Spring S.B. Extragenic suppression of temperature-sensitive mutations in RNA segment 8 by replacement of different rna segments with those of other influenza A virus prototype strains. Virology. 118:1982;28-34.
16. Simonsen L., Clarke M.J., Williamson G.D., Stroup D.F., Arden N.H., Schonberger L.B. The impact of influenza epidemics on mortality introducing a severity index. Am. J. Public Health. 87:1997;1944-1950.
17. Snyder M.H., Betts R.F., DeBorde D., Tierney E.L., Clements M.L., Herrington D., Sears S.D., Dolin R., Maassab H.F., Murphy B.R. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J. Virol. 62:1988;488-495.
18. Subbarao E.K., Park E.J., Lawson C.M., Chen A.Y., Murphy B.R. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. J. Virol. 69:1995;5969-5977.
19. Subbarao E.K., Perkins M., Treanor J.J., Murphy B.R. The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect. Virus Res. 25:1992;37-50.
20. Wright P.F., Webster R. Orthomyxoviruses. Knipe D.M., Howley P.M. Fields Virology. Vol. 1. 2 vols:2001;1533-1579 Lippincott, Williams, & Wilkins, Philadelphia.